Apexigen, Inc.
CIK 0001814140
Revenue (TTM)
—
Q2 Aug 2023
Net Income (TTM)
−$28.7M
−10.9% YoY
Q2 Aug 2023
EPS Diluted (TTM)
−$1.35
−1.3% YoY
Q2 Aug 2023
Gross Margin
—
Q2 Aug 2023
Operating Margin
—
Q2 Aug 2023
Net Margin
—
Q2 Aug 2023
Free Cash Flow (TTM)
−$30.75M
Q2 Aug 2023
Cash
$9.37M
Q2 Aug 2023
Total Debt
—
Q2 Aug 2023
Shares Outstanding
24.86M sh
Q2 Aug 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.